The IMI Governing Board, the decision-making body of the IMI Joint Undertaking (IMI JU), met on March 3 to kick-off the work of the Innovative Medicines Initiative in its attempt to overcome bottlenecks in European pharmaceutical R&D and support biomedical research for the benefit of patients.

The Council Regulation setting up the Innovative Medicines Joint Undertaking was published in the Official Journal

The Council of the European Union today formally approved the Regulation setting up the Innovative Medicines Initiative (IMI)

The Members of the European Parliament show support for the Innovative Medicines Initiative (IMI)

The Council reached a "general approach" (substantial elements of the legal acts) on four proposals aimed at establishing joint technology initiatives (JTIs).

The Competitiveness Council reached on September 28 a common understanding on main elements related to four proposals aimed at establishing Joint Technology Initiatives

The Council heard a presentation by the Commission on proposals for setting up the first two joint technology initiatives (JTIs) for European research on embedded computer systems (“ARTEMIS”) and innovative medicines (“IMI”) (9685/07 and 9686/07).

The European Federation of Pharmaceutical Industries and Associations (EFPIA) welcomes the commitment made today by the European Commission, to establish the Innovative Medicines Initiative (IMI) in partnership with the European biopharmaceutical industry.

On March 30th, DG Research launched the official InterService Consultation (ISC) for IMI within the European Commission.

At the Competitiveness Council meeting on 30 May 2006, the Commissioner announced that a Roadmap would be presented in autumn 2006, outlining the Commission's intentions for the Joint Technology Initiatives. The Roadmap documents is now released.